Magliano DJ, Chen L, Morton JI, Salim A, Carstensen B, Gregg EW, Pavkov ME, Arffman M, Colhoun HM, Ha KH, Imamura T. Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortium. Lancet Diabet Endocrinol. 2024;12(12):915–23.
Google Scholar
Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, Zhang Y, Shen S, Tong N. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther. 2024;9(1):262.
Google Scholar
Ferrannini G, Tuomilehto J, De Backer G, Kotseva K, Mellbin L, Schnell O, Wood D, De Bacquer D, Rydén L. Dysglycaemia screening and its prognostic impact in patients with coronary artery disease: experiences from the EUROASPIRE IV and V cohort studies. Lancet Diabetes Endocrinol. 2024;12(11):790–8.
Google Scholar
Tan C, Williams Z, Islam MA, Kelly R, Esgin T, Ekinci EI. Interventions for aboriginal and Torres strait Islander people with type 2 diabetes that modify its management and cardiometabolic risk factors: a systematic review. Med J Aust. 2024. https://doi.org/10.5694/mja5692.52508.
Google Scholar
Neeland IJ, Lim S, Tchernof A, Gastaldelli A, Rangaswami J, Ndumele CE, Powell-Wiley TM, Després J-P. Metabolic syndrome. Nat Rev Dis Primers. 2024;10(1):77.
Google Scholar
Kelly RJ, Macniven R, Churilov L, Morris MJ, O’Neal D, Ekinci EI. Physical activity interventions to prevent and manage type 2 diabetes in aboriginal and Torres Strait Islander people: a systematic review. Med J Aust. 2024;221(9):486–90.
Google Scholar
Bacha F, Hannon TS, Tosur M, Pike JM, Butler A, Tommerdahl KL, Zeitler PS. Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth. Diabetes Care. 2024;47(12):2038-49.
Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, Halpern B, Wharton S, Wilding JPH, Perreault L, Zhang S, Battula R, et al. Tirzepatide for obesity treatment and diabetes prevention. N Engl J Med. 2024. https://doi.org/10.1056/NEJMoa2410819.
Google Scholar
Wu X, Ying H, Yang Q, Yang Q, Liu H, Ding Y, Zhao H, Chen Z, Zheng R, Lin H, et al. Transcriptome-wide Mendelian randomization during CD4+ T cell activation reveals immune-related drug targets for cardiometabolic diseases. Nat Commun. 2024;15(1):9302.
Google Scholar
Schöneberg T. Modulating vertebrate physiology by genomic fine-tuning of GPCR functions. Physiol Rev. 2025;105(1):383–439.
Google Scholar
Cahill LE, Warren RA, Carew AS, Levy AP, Sapp J, Samuel M, Selvin E, Lavallée SK, Poulter N, Marre M, et al. Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type 2 diabetes: the ADVANCE study. Diabetes Care. 2024;47(5):835–43.
Google Scholar
Topol EJ. The revolution in high-throughput proteomics and AI. Science. 2024;385(6716):eads5749.
Google Scholar
Zheng Y, Li J, Li Y, Wang J, Suo C, Jiang Y, Jin L, Xu K, Chen X. Plasma proteomic profiles reveal proteins and three characteristic pat terns associated with osteoporosis: a prospective cohort study. J Adv Res. 2024;S2090–1232:00474–1470.
Larsson SC, Butterworth AS, Burgess S. Mendelian randomization for cardiovascular diseases: principles and applications. Eur Heart J. 2023;44(47):4913–24.
Google Scholar
Allen NE, Lacey B, Lawlor DA, Pell JP, Gallacher J, Smeeth L, Elliott P, Matthews PM, Lyons RA, Whetton AD, et al. Prospective study design and data analysis in UK Biobank. Sci Transl Med. 2024;16(729):eadf4428.
Google Scholar
Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, Gunnarsdottir K, Helgason A, Oddsson A, Halldorsson BV, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53(12):1712.
Google Scholar
Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508–18.
Google Scholar
Sun BB, Chiou J, Traylor M, Benner C, Hsu Y-H, Richardson TG, Surendran P, Mahajan A, Robins C, Vasquez-Grinnell SG, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622(7982):329–38.
Google Scholar
Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, Bork P. The STRING database in 2023: protein–protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucl Acids Res. 2023;51(D1):D638–46.
Google Scholar
Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.
Google Scholar
Si S, Liu H, Xu L, Zhan S. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome. Genome Med. 2024;16(1):84.
Google Scholar
Cannon M, Stevenson J, Stahl K, Basu R, Coffman A, Kiwala S, McMichael JF, Kuzma K, Morrissey D, Cotto K, et al. DGIdb 5.0: rebuilding the drug-gene interaction database for precision medicine and drug discovery platforms. Nucl Acids Res. 2024;52(D1):D1227–35.
Google Scholar
Sun Y, Li Y, Ding X, Xu P, Jing X, Cong H, Hu H, Yu B, Xu F-J. An NIR-responsive hydrogel loaded with polydeoxyribonucleotide nano-vectors for enhanced chronic wound healing. Biomaterials. 2025;314:122789.
Google Scholar
Chowdhary A, Thirunavukarasu S, Joseph T, Jex N, Kotha S, Giannoudi M, Procter H, Cash L, Akkaya S, Broadbent D, et al. Liraglutide improves myocardial perfusion and energetics and exercise tolerance in patients with type 2 diabetes. J Am Coll Cardiol. 2024;84(6):540–57.
Google Scholar
Christodoulou A, Nikolaou P-E, Symeonidi L, Katogiannis K, Pechlivani L, Nikou T, Varela A, Chania C, Zerikiotis S, Efentakis P, et al. Cardioprotective potential of oleuropein, hydroxytyrosol, oleocanthal and their combination: unravelling complementary effects on acute myocardial infarction and metabolic syndrome. Redox Biol. 2024;76:103311.
Google Scholar
Crane JD, Joy G, Knott KD, Augusto JB, Lau C, Bhuva AN, Seraphim A, Evain T, Brown LAE, Chowdhary A, et al. The impact of bariatric surgery on coronary microvascular function assessed using automated quantitative perfusion CMR. JACC Cardiovasc Imaging. 2024;17(11):1305–16.
Google Scholar
Marston NA, Pirruccello JP, Melloni GEM, Kamanu F, Bonaca MP, Giugliano RP, Scirica BM, Wiviott SD, Bhatt DL, Steg PG, et al. Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials. Nat Med. 2024;30(9):2641–7.
Google Scholar
McClintick DJ, O’Donoghue ML, De Ferrari GM, Ferreira J, Ran XH, Im K, Elliott-Davey M, Wang B, Monsalvo ML, Atar D, et al. Long-term efficacy of evolocumab in patients with or without multivessel coronary disease. J Am Coll Cardiol. 2024;83(6):652–64.
Google Scholar
Gibson CM, Duffy D, Bahit MC, Chi G, White H, Korjian S, Alexander JH, Lincoff AM, Heise M, Kingwell BA, Nicolau JC. Apolipoprotein AI infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial. Eur Heart J. 2024;45(47):5023–38.
Google Scholar
Zahger D, Schwartz GG, Du W, Szarek M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Jukema JW, et al. Triglyceride levels, alirocumab treatment, and cardiovascular outcomes after an acute coronary syndrome. J Am Coll Cardiol. 2024;84(11):994–1006.
Google Scholar
Li D, Yang K, Li J, Xu X, Gong L, Yue S, Wei H, Yue Z, Wu Y, Yin S. Single-cell sequencing reveals glial cell involvement in development of neuropathic pain via myelin sheath lesion formation in the spinal cord. J Neuroinflamm. 2024;21(1):213.
Google Scholar
Liu T, Zhang J, Chang F, Sun M, He J, Ai D. Role of endothelial Raptor in abnormal arteriogenesis after lower limb ischaemia in type 2 diabetes. Cardiovasc Res. 2024;120(10):1218–34.
Google Scholar
Schmidt AF, Swerdlow DI, Holmes MV, Patel RS, Fairhurst-Hunter Z, Lyall DM, Hartwig FP, Horta BL, Hyppönen E, Power C, et al. PCSK9 genetic variants and risk of type 2 diabetes: a Mendelian random isation study. Lancet Diabetes Endocrinol. 2017;5(2):97–105.
Google Scholar
Banach M, Reiner Ž, Surma S, Bajraktari G, Bielecka-Dabrowa A, Bunc M, Bytyçi I, Ceska R, Cicero AF, Dudek D, Dyrbuś K. 2024 recommendations on the optimal use of lipid-lowering therapy in established atherosclerotic cardiovascular disease and following acute coronary syndromes: a position paper of the international lipid expert panel (ILEP). Drugs. 2024;4:1–37. https://doi.org/10.1007/s40265-40024-02105-40265.
Google Scholar
Xing M, Chen W, Ji Y, Song W. SLC44A2-mediated phenotypic switch of vascular smooth muscle cells contributes to aortic aneurysm. J Clin Invest. 2024;134(16):e183527.
Google Scholar
Gibson A, Ram R, Gangula R, Li Y, Mukherjee E, Palubinsky AM, Campbell CN, Thorne M, Konvinse KC, Choshi P, et al. Multiomic single-cell sequencing defines tissue-specific responses in Stevens–Johnson syndrome and toxic epidermal necrolysis. Nat Commun. 2024;15(1):8722.
Google Scholar
Gorgulho J, Loosen SH, Masood R, Giehren F, Pagani F, Buescher G, Kocheise L, Joerg V, Schmidt C, Schulze K, et al. Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy. J Exp Clin Cancer Res. 2024;43(1):298.
Google Scholar
Gunawardhana KL, Hong L, Rugira T, Uebbing S, Kucharczak J, Mehta S, Karunamuni DR, Cabera-Mendoza B, Gandotra N, Scharfe C, et al. A systems biology approach identifies the role of dysregulated PRDM6 in the development of hypertension. J Clin Invest. 2023;133(4):e160036.
Google Scholar
Dewan P, Ferreira JP, Butt JH, Petrie MC, Abraham WT, Desai AS, Dickstein K, Køber L, Packer M, Rouleau JL, et al. Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARAD IGM-HF and ATMOSPHERE. Eur J Heart Fail. 2023;25(5):687–97.
Google Scholar
Ray KK, Colhoun HM, Szarek M. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial (vol 7, pg 618, 2019). Lancet Diabetes Endo. 2019;7(9):E21–E21.
Mordi IR, Li I, George G, McCrimmon RJ, Palmer CN, Pearson ER, Lang CC, Doney AS. Incremental prognostic value of a coronary heart disease polygenic risk score in type 2 diabetes. Diabetes Care. 2024;47(12):2223–9.
Google Scholar
Zhang Y, Yu S, Chen Z, Liu H, Li H, Long X, Ye F, Luo W, Dai Y, Tu S, Chen W. Gestational diabetes and future cardiovascular diseases: associations by sex-specific genetic data. Eur Heart J. 2024;45(48):5156–67.
Google Scholar
Brito EC, Vimaleswaran KS, Brage S, Andersen LB, Sardinha LB, Wareham NJ, Ekelund U, Loos RJF, Franks PW. PPARGC1A sequence variation and cardiovascular risk-factor levels: a study of the main genetic effects and gene x environment interactions in children from the European youth heart study. Diabetologia. 2009;52(4):609–13.
Google Scholar
Meadows DH, Jardetzky O. Nuclear magnetic resonance studies of the structure and binding sites of enzymes. IV. Cytidine 3’-monophosphate binding to ribonuclease. Proc Natl Acad Sci USA. 1968;61(2):406–13.
Google Scholar
Zeng X, Wang Y, Farias K, Rappa A, Darko C, Sauve A, Huang Q, Alonso LC, Yang Y. NRH, a potent NAD+ enhancer, improves glucose homeostasis and lipid metabolism in diet-induced obese mice through an active adenosine kinase pathway. Metabolism. 2025;164:156110.
Google Scholar
Sprinkles JK, Lulla A, Hullings AG, Trujillo-Gonzalez I, Klatt KC, Jacobs DR Jr, Shah RV, Murthy VL, Howard AG, Gordon-Larsen P, et al. Choline metabolites and 15-year risk of incident diabetes in a prospective cohort of adults: coronary artery risk development in young adult s (CARDIA) study. Diabetes Care. 2024;47(11):1985–94.
Google Scholar
link